-
Solving COVID: October 28, 2020
feature A drop in COVID death rates, new data about school infections, and more
feature -
Solving COVID: October 21, 2020
feature Healthy volunteers to be intentionally infected, Oxford creates 5-minute COVID test, and more
feature -
Solving COVID: October 14, 2020
feature Inhaled vaccines are under development, Eli Lilly pauses its treatment trial, and more
feature -
Solving COVID: October 7, 2020
feature Researchers create a paper coronavirus test, study finds antibody cocktail shortens recovery time, and more
feature -
Solving COVID: September 30, 2020
feature Rapid tests for lower income countries, encouraging results from ongoing vaccine trials, and more
feature -
Solving COVID: September 23, 2020
feature Single-shot vaccine trial starts phase 3, an at-home test delivers quick results, and more
feature -
Solving COVID: September 16, 2020
feature AstraZeneca vaccine trials resume, antibody drug sees promising results, and more
feature -
Solving COVID: September 9, 2020
feature Common steroids reduce death risk, drug makers release safety pledge, and more
feature -
Solving COVID: September 2, 2020
feature AstraZeneca starts Phase 3 vaccine trial in U.S., researchers learn more about COVID reinfection, and more
feature -
Solving COVID: August 26, 2020
feature Researchers increasingly confident about COVID-19 vaccine by January, breathalyzer test prototype promises results in 30 seconds, and more
feature -
Solving COVID: August 19, 2020
feature Good news about immunity, the power of mask mandates, and more
feature -
Solving COVID: August 12, 2020
feature Russia claims victory in vaccine race though scientists have major doubts, U.S. to buy 100 million doses of Moderna vaccine, and more
feature -
Solving COVID: August 5, 2020
feature Novavax vaccine produces strong antibody response, state governors team up to expand testing, and more
feature -
Solving COVID: July 29, 2020
feature Moderna starts dosing volunteers, good news about loss of smell, and more
feature
